The goal of the European Network of Centers for Pharmacoepidemiology and Pharmacovigilance (ENCePP) is to facilitate independent and transparent post-authorization monitoring of medicinal products in Europe.
Updates
Join RTI Health Solutions researchers as they teach Budget Impact Analysis.
Allen Mangel, MD, PhD, and Executive VP of RTI-HS, examines evidence that supports a different understanding of the behavior of the aorta during the cardiac cycle.
RTI Health Solutions is pleased to announce that Ken Rothman, DrPH, Distinguished Fellow and Vice President for Epidemiology Research, has been awarded the Career Accomplishment Award by the Society for Epidemiologic Research.
This webinar explores the trends in PRO-related product labeling and highlights key observations. Knowing the trends and the lessons learned from this review of US product labeling will enable you to formulate better PRO labeling strategies.
RTI Health Solutions has joined a collaborative led by the Medical Device Innovation Consortium that will work with Parkinson’s patients to determine the benefit and risk tradeoffs they are willing to make for potential new therapies.
Data from a head-to-head trial showed that LDX is a cost-effective treatment option compared with atomoxetine in children and adolescents who have had an inadequate response to the currently recommended first-line stimulant treatment.